Literature DB >> 16809721

We still need artesunate monotherapy.

François Nosten, Elizabeth Ashley, Rose McGready, Ric Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16809721      PMCID： PMC1488766          DOI： 10.1136/bmj.333.7557.45

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  WHO ultimatum on artemisinin monotherapy is showing results.

Authors:  Christiane Rehwagen
Journal:  BMJ       Date:  2006-05-20

2.  Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum.

Authors:  R McGready; T Cho; N K Keo; K L Thwai; L Villegas; S Looareesuwan; N J White; F Nosten
Journal:  Clin Infect Dis       Date:  2001-11-09       Impact factor: 9.079

3.  Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria.

Authors:  R Price; C Luxemburger; M van Vugt; F Nosten; A Kham; J Simpson; S Looareesuwan; T Chongsuphajaisiddhi; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Mar-Apr       Impact factor: 2.184

4.  Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.

Authors:  R McGready; K Stepniewska; S A Ward; T Cho; G Gilveray; S Looareesuwan; N J White; F Nosten
Journal:  Eur J Clin Pharmacol       Date:  2006-03-22       Impact factor: 2.953

5.  Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.

Authors:  C Luxemburger; F Nosten; S D Raimond; T Chongsuphajaisiddhi; N J White
Journal:  Am J Trop Med Hyg       Date:  1995-11       Impact factor: 2.345
  5 in total
  3 in total

1.  A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance.

Authors:  Sivong Sengaloundeth; Michael D Green; Facundo M Fernández; Ot Manolin; Khamlieng Phommavong; Vongsavanh Insixiengmay; Christina Y Hampton; Leonard Nyadong; Dallas C Mildenhall; Dana Hostetler; Lamphet Khounsaknalath; Latsamy Vongsack; Samlane Phompida; Viengxay Vanisaveth; Lamphone Syhakhang; Paul N Newton
Journal:  Malar J       Date:  2009-07-28       Impact factor: 2.979

2.  Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b study.

Authors:  Robert Scott Miller; Qigui Li; Louis R Cantilena; Kevin J Leary; George A Saviolakis; Victor Melendez; Bryan Smith; Peter J Weina
Journal:  Malar J       Date:  2012-08-01       Impact factor: 2.979

3.  Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication.

Authors:  Susan Obeid; Jo Alen; Van Hung Nguyen; Van Cuong Pham; Philip Meuleman; Christophe Pannecouque; Thanh Nguyen Le; Johan Neyts; Wim Dehaen; Jan Paeshuyse
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.